News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kearns Evan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2022 |
4
| Kearns Evan (Chief Legal Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 202,250 options to buy
@ $7.6, valued at
$1.5M
|
|
| 05/05/2021 |
4
| Kearns Evan (Chief Legal Officer) has filed a Form 4 on Cogent Biosciences, Inc.|
Txns:
| Granted 260,000 options to buy
@ $8.93, valued at
$2.3M
|
|
| 05/05/2021 |
3
| Kearns Evan (Chief Legal Officer) has filed a Form 3 on Cogent Biosciences, Inc. |
| 12/21/2020 |
4
| Kearns Evan (VP and General Counsel) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 150,000 options to buy
@ $3.7, valued at
$555k
|
|
| 12/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2019 |
4
| Kearns Evan (VP and General Counsel) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 18,333 options to buy
@ $2.39, valued at
$43.8k
|
|
| 06/21/2019 |
4
| Kearns Evan (V.P. and General Counsel) has filed a Form 4 on AGENUS INC|
Txns:
| Granted 200,000 options to buy
@ $2.38, valued at
$476k
|
|
| 07/13/2018 |
3
| Kearns Evan (VP, General Counsel) has filed a Form 3 on AGENUS INC |
|
|